http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070215-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f928cb5f71480c5fadfbc40a433d97e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4893248a27519769e05bfda5677353bd
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
filingDate 2003-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05e2c593ef1f8ed472bcf7ce4ca0fedc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9ac614b053397e2dea2fd95135336b2
publicationDate 2003-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03070215-A1
titleOfInvention Powder inhalation containing cgrp-antagonist bibn4096 and method for the production thereof
abstract The invention relates to powder inhalation for the treatment of migraines, comprising the CGRP-antagonists 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazin [BIBN4096] of formula I as an active substance base in the form of spherical nanostructured particles and a method for the production thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018603-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018614-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018604-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018604-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018603-A2
priorityDate 2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10139410-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0132144-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-1792207-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0110425-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228378078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592286
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918509

Total number of triples: 36.